Variant report

Variant	esv3353004
Chromosome Location	chr10:26912762-26966282
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:483)
CpG islands
(count:794)
Chromatin interactive
region (count:17)
LncRNA
region (count:15)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:483 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr10:26964570-26964881	K562	blood:	n/a	n/a
2	ATF2	chr10:26917400-26917850	GM12878	blood:	n/a	n/a
3	ATF2	chr10:26917389-26917782	GM12878	blood:	n/a	n/a
4	ATF3	chr10:26926570-26926744	K562	blood:	n/a	chr10:26926582-26926591
5	ATF3	chr10:26954068-26954353	K562	blood:	n/a	n/a
6	BATF	chr10:26917429-26917718	GM12878	blood:	n/a	n/a
7	BATF	chr10:26917280-26917726	GM12878	blood:	n/a	n/a
8	BCL11A	chr10:26917343-26917726	GM12878	blood:	n/a	n/a
9	BHLHE40	chr10:26917448-26917722	GM12878	blood:	n/a	n/a
10	BHLHE40	chr10:26962966-26962980	K562	blood:	n/a	n/a
11	BHLHE40	chr10:26926497-26926757	K562	blood:	n/a	n/a
12	BHLHE40	chr10:26963417-26963432	K562	blood:	n/a	n/a
13	BRCA1	chr10:26952423-26952612	Hela-S3	cervix:	n/a	n/a
14	CBX3	chr10:26964318-26964954	K562	blood:	n/a	n/a
15	CEBPB	chr10:26925024-26925342	IMR90	lung:	n/a	n/a
16	CEBPB	chr10:26925026-26925341	HepG2	liver:	n/a	n/a
17	CEBPB	chr10:26946966-26947172	K562	blood:	n/a	n/a
18	CEBPB	chr10:26961963-26962323	K562	blood:	n/a	chr10:26962123-26962134
19	CEBPB	chr10:26954028-26954383	IMR90	lung:	n/a	chr10:26954199-26954210
20	CEBPB	chr10:26962043-26962214	HepG2	liver:	n/a	chr10:26962123-26962134
21	CEBPB	chr10:26954005-26954489	K562	blood:	n/a	chr10:26954199-26954210
22	CEBPB	chr10:26946921-26947139	HepG2	liver:	n/a	n/a
23	CEBPB	chr10:26954017-26954298	K562	blood:	n/a	chr10:26954199-26954210
24	CEBPB	chr10:26961963-26962220	IMR90	lung:	n/a	chr10:26962123-26962134
25	CEBPB	chr10:26925020-26925337	A549	lung:	n/a	n/a
26	CEBPB	chr10:26954040-26954379	HepG2	liver:	n/a	chr10:26954199-26954210
27	CEBPB	chr10:26925018-26925342	K562	blood:	n/a	n/a
28	CEBPB	chr10:26954081-26954382	H1-hESC	embryonic stem cell:	n/a	chr10:26954199-26954210
29	CEBPB	chr10:26954017-26954389	A549	lung:	n/a	chr10:26954199-26954210
30	CEBPD	chr10:26954260-26954812	K562	blood:	n/a	n/a
31	CHD2	chr10:26955538-26955614	K562	blood:	n/a	n/a
32	CTCF	chr10:26916320-26916470	GM12874	blood:	n/a	n/a
33	CTCF	chr10:26955743-26955819	GM13976	blood:	n/a	n/a
34	CTCF	chr10:26936656-26936835	MCF-7	breast:	n/a	n/a
35	CTCF	chr10:26916380-26916530	RPTEC	kidney:	n/a	n/a
36	CTCF	chr10:26936680-26936830	HepG2	liver:	n/a	n/a
37	CTCF	chr10:26936640-26936790	GM12874	blood:	n/a	n/a
38	CTCF	chr10:26916378-26916552	A549	lung:	n/a	n/a
39	CTCF	chr10:26936660-26936810	SAEC	small airway:	n/a	n/a
40	CTCF	chr10:26916380-26916530	HRE	kidney:	n/a	n/a
41	CTCF	chr10:26916374-26916532	LNCaP	prostate:	n/a	n/a
42	CTCF	chr10:26926824-26926911	GM19240	blood:	n/a	n/a
43	CTCF	chr10:26936652-26936841	GM12878	blood:	n/a	n/a
44	CTCF	chr10:26936640-26936790	NHEK	skin:	n/a	n/a
45	CTCF	chr10:26936620-26936770	GM12866	blood:	n/a	n/a
46	CTCF	chr10:26916420-26916570	HAc	cerebellar:	n/a	n/a
47	CTCF	chr10:26916400-26916550	HVMF	connective:	n/a	n/a
48	CTCF	chr10:26934800-26934950	GM12865	blood:	n/a	n/a
49	CTCF	chr10:26916320-26916470	HCFaa	heart:	n/a	n/a
50	CTCF	chr10:26916320-26916470	GM12872	blood:	n/a	n/a

(count:794 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr10:26932057-26932107	GM19239	blood:	n/a
2	chr10:26932057-26932107	GM19239	blood:	n/a
3	chr10:26931731-26931781	LNCaP	prostate:	n/a
4	chr10:26932057-26932107	Hela-S3	cervix:	n/a
5	chr10:26932036-26932086	SKMC	muscle:	n/a
6	chr10:26931969-26932019	AG09319	gingival:	n/a
7	chr10:26931991-26932041	T-47D	breast:	n/a
8	chr10:26942225-26942275	AG04450	lung:	fetal
9	chr10:26931926-26931976	GM06990	blood:	n/a
10	chr10:26931794-26931844	A549	lung:	n/a
11	chr10:26931731-26931781	T-47D	breast:	n/a
12	chr10:26942165-26942215	ovcar-3	ovarian:	n/a
13	chr10:26931986-26932036	PANC-1	pancreas:	n/a
14	chr10:26942225-26942275	HCM	heart:	n/a
15	chr10:26931794-26931844	BJ	skin:	n/a
16	chr10:26931926-26931976	HEK293	kidney:	embryo
17	chr10:26931794-26931844	HCT-116	colon:	n/a
18	chr10:26931926-26931976	AG10803	skin:	n/a
19	chr10:26942165-26942215	AG10803	skin:	n/a
20	chr10:26931794-26931844	GM12891	blood:	n/a
21	chr10:26931969-26932019	NHDF-neo	bronchial:	n/a
22	chr10:26932057-26932107	AG10803	skin:	n/a
23	chr10:26931731-26931781	AG04449	skin:	fetal
24	chr10:26931731-26931781	PANC-1	pancreas:	n/a
25	chr10:26931794-26931844	NB4	blood:	n/a
26	chr10:26931986-26932036	NB4	blood:	n/a
27	chr10:26931986-26932036	HAEpiC	amniotic membrane:	n/a
28	chr10:26942225-26942275	NB4	blood:	n/a
29	chr10:26931986-26932036	MCF-7	breast:	n/a
30	chr10:26930863-26930913	HMEC	breast:	n/a
31	chr10:26931912-26931962	GM12892	blood:	n/a
32	chr10:26931991-26932041	HRCEpiC	kidney:	n/a
33	chr10:26931991-26932041	H1-hESC	embryonic stem cell:	embryo
34	chr10:26932057-26932107	NB4	blood:	n/a
35	chr10:26931731-26931781	HEK293	kidney:	embryo
36	chr10:26931986-26932036	NHBE	bronchial:	n/a
37	chr10:26931926-26931976	HCM	heart:	n/a
38	chr10:26932036-26932086	SK-N-SH_RA	brain:	n/a
39	chr10:26932057-26932107	HMEC	breast:	n/a
40	chr10:26931991-26932041	HepG2	liver:	n/a
41	chr10:26931978-26932028	NB4	blood:	n/a
42	chr10:26931991-26932041	NB4	blood:	n/a
43	chr10:26931969-26932019	NB4	blood:	n/a
44	chr10:26931912-26931962	GM12891	blood:	n/a
45	chr10:26931912-26931962	CMK	blood:	n/a
46	chr10:26930863-26930913	SK-N-SH_RA	brain:	n/a
47	chr10:26931969-26932019	AG04449	skin:	fetal
48	chr10:26931978-26932028	HRPEpiC	eye:	n/a
49	chr10:26931978-26932028	K562	blood:	n/a
50	chr10:26931991-26932041	HRPEpiC	eye:	n/a

(count:17 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr10:26953025..26955897-chr10:26956336..26959208,3	K562	blood:
2	chr10:26948657..26951534-chr10:26954538..26957242,4	K562	blood:
3	chr10:26958878..26961575-chr10:26966609..26969572,2	K562	blood:
4	chr10:26965108..26970102-chr10:26984839..26987979,6	K562	blood:
5	chr10:26942956..26945018-chr10:26949482..26951597,3	K562	blood:
6	chr10:26952451..26954548-chr10:26967592..26969154,2	K562	blood:
7	chr10:26942956..26944932-chr10:26949482..26951411,2	K562	blood:
8	chr10:26942956..26945018-chr10:26949482..26951597,3	K562	blood:
9	chr10:26961383..26963009-chr10:26967023..26968974,2	K562	blood:
10	chr10:26942956..26944932-chr10:26949482..26951411,2	K562	blood:
11	chr10:26944728..26946269-chr10:26952549..26954691,2	K562	blood:
12	chr10:26948657..26951534-chr10:26954538..26957242,4	K562	blood:
13	chr10:26953025..26955897-chr10:26956336..26959208,3	K562	blood:
14	chr10:26944728..26946269-chr10:26952549..26954691,2	K562	blood:
15	chr10:26965218..26966801-chr10:26966890..26969574,2	K562	blood:
16	chr10:26954305..26956450-chr10:26987430..26988975,2	K562	blood:
17	chr10:26955921..26958837-chr10:26961876..26965160,3	K562	blood:

(count:15 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-APBB1IP-3	chr10:26921785-26921901	NONHSAT011843
2	lnc-PDSS1-1	chr10:26938261-26938522	ENSG00000231976
3	lnc-ABI1-1	chr10:26957336-26957423	ENSG00000227932.1
4	lnc-ABI1-1	chr10:26953135-26953321	ENSG00000227932.1
5	lnc-APBB1IP-3	chr10:26922869-26923259	NONHSAT011843
6	lnc-PDSS1-1	chr10:26937880-26937946	NONHSAT011834
7	lnc-PDSS1-1	chr10:26941994-26942040	ENSG00000231976
8	lnc-PDSS1-1	chr10:26939483-26939586	ENSG00000231976
9	lnc-PDSS1-1	chr10:26932157-26932525	XLOC_008421
10	lnc-ABI1-1	chr10:26965045-26965088	ENSG00000227932.1
11	lnc-PDSS1-1	chr10:26939483-26939691	NONHSAT011840
12	lnc-APBB1IP-3	chr10:26920245-26920348	NONHSAT011843
13	lnc-APBB1IP-3	chr10:26918800-26919272	NONHSAT011843
14	lnc-PDSS1-1	chr10:26933843-26933945	XLOC_008421
15	lnc-PDSS1-1	chr10:26937187-26937211	NONHSAT011834

No data

Variant related genes	Relation type
ENSG00000234296	TF binding region
ENSG00000227932	TF binding region
LINC00202-2	TF binding region
ENSG00000234296	CpG island
ENSG00000227932	CpG island
LINC00202-2	CpG island
ENSG00000227932	chromatin interactions
ENSG00000148459	chromatin interactions
PDGFRA	miRNA target sites
DNMT1	miRNA target sites

Extended variants
information (count: 2628 )
Associated
traits (count: 42 )

Variant overlapped rSNPs/rCNVs (count:2628 , 50 per page) page: 1 2 3 4 5 6 7 ... 53

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs564105284	chr10:26912763-26912764	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs532947673	chr10:26912764-26912765	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs543588742	chr10:26912778-26912779	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs117446843	chr10:26912783-26912784	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs528941451	chr10:26912839-26912840	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs548777225	chr10:26912904-26912905	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs146687772	chr10:26912934-26912935	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs528014692	chr10:26912939-26912940	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs190114802	chr10:26912945-26912946	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs570561354	chr10:26912954-26912955	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs148832537	chr10:26912969-26912970	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs556101240	chr10:26912977-26912978	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs569834199	chr10:26912983-26912984	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs116144569	chr10:26912986-26912987	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs142510467	chr10:26912998-26912999	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs572133848	chr10:26913028-26913029	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs191985221	chr10:26913031-26913032	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs184058766	chr10:26913077-26913078	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs577963012	chr10:26913111-26913112	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs151011346	chr10:26913132-26913133	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs188393839	chr10:26913142-26913143	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs529003547	chr10:26913146-26913147	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs140862785	chr10:26913147-26913148	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs562340066	chr10:26913180-26913181	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs138799513	chr10:26913267-26913268	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs141311854	chr10:26913279-26913280	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs557725134	chr10:26913341-26913342	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs570821779	chr10:26913384-26913385	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs111892111	chr10:26913393-26913394	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs549786158	chr10:26913406-26913407	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs569929113	chr10:26913474-26913475	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs535979731	chr10:26913482-26913483	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs555572272	chr10:26913517-26913518	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs577249039	chr10:26913522-26913523	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs368734800	chr10:26913527-26913528	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs180861231	chr10:26913531-26913532	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs578010465	chr10:26913544-26913545	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs543710055	chr10:26913558-26913559	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs147071362	chr10:26913601-26913602	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs573539543	chr10:26913604-26913605	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs542746303	chr10:26913620-26913621	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs114774814	chr10:26913661-26913662	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs138385383	chr10:26913677-26913678	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs149574675	chr10:26913687-26913688	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs186145959	chr10:26913698-26913699	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs541896489	chr10:26913703-26913704	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs78665621	chr10:26913713-26913714	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs78433534	chr10:26913716-26913717	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs533473715	chr10:26913720-26913721	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs116735892	chr10:26913728-26913729	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:42)

Disease	PMID	Source
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Glioblastoma multiforme	21080181	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Phyllodes tumor	17334353	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Gastric cancer	17908304	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Medulloblastoma	21979893	CNVD
Melanoma	18172304	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Lung cancer	18438408	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Ewing''s sarcoma	17952124	CNVD
Oral cancer	21386901	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	20724749	CNVD
Autism	22495311	CNVD
T-cell lymphomas	19863542	CNVD
Esophageal cancer	21851588	CNVD
small cell lung cancer	20016488	CNVD
Behavioral abnormalities	21522184	CNVD
Dysmorphic features	21522184	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Myelofibrosis	22110671	CNVD
Autism	21439084	CNVD
Maculopathy	20981449	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Adrenocortical carcinoma	18281524	CNVD
Breast cancer	21364760	CNVD
abnormal development	18461090	CNVD
Non-syndromic sensorineural hearing loss	17431168	CNVD

Chromatin state (count:89 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr10:26912000-26913200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
2	chr10:26912000-26926400	Weak transcription	Thymus	Thymus
3	chr10:26912200-26916400	Weak transcription	Primary monocytes fromperipheralblood	blood
4	chr10:26912200-26916400	Weak transcription	Monocytes-CD14+_RO01746	blood
5	chr10:26912200-26917400	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
6	chr10:26912400-26916600	Weak transcription	Primary hematopoietic stem cells short term culture	blood
7	chr10:26912600-26913600	Weak transcription	Liver	Liver
8	chr10:26913200-26917600	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
9	chr10:26913600-26915600	Enhancers	Liver	Liver
10	chr10:26915600-26916000	Flanking Active TSS	Liver	Liver
11	chr10:26916000-26916600	Enhancers	Liver	Liver
12	chr10:26916200-26916400	Enhancers	HUES6 Cell Line	embryonic stem cell
13	chr10:26916400-26916600	Bivalent Enhancer	Rectal Mucosa Donor 31	rectum
14	chr10:26916400-26917400	Enhancers	Monocytes-CD14+_RO01746	blood
15	chr10:26916400-26918200	Enhancers	Primary monocytes fromperipheralblood	blood
16	chr10:26916600-26918200	Enhancers	Primary hematopoietic stem cells short term culture	blood
17	chr10:26917400-26917800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
18	chr10:26917400-26917800	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
19	chr10:26917600-26918000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
20	chr10:26917800-26918400	Enhancers	Monocytes-CD14+_RO01746	blood
21	chr10:26926400-26927000	Enhancers	Thymus	Thymus
22	chr10:26927000-26927800	Weak transcription	Thymus	Thymus
23	chr10:26927000-26928200	Active TSS	Fetal Thymus	thymus
24	chr10:26927800-26928200	Active TSS	Thymus	Thymus
25	chr10:26928200-26928800	Weak transcription	Thymus	Thymus
26	chr10:26928200-26929000	Weak transcription	Fetal Thymus	thymus
27	chr10:26928800-26929600	Enhancers	Thymus	Thymus
28	chr10:26929000-26929200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
29	chr10:26929000-26929600	Enhancers	Fetal Thymus	thymus
30	chr10:26929200-26929400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
31	chr10:26929400-26929600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
32	chr10:26929600-26934800	Weak transcription	Thymus	Thymus
33	chr10:26929600-26936400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
34	chr10:26930600-26936400	Weak transcription	Right Atrium	heart
35	chr10:26931600-26932800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
36	chr10:26932000-26932400	Enhancers	Gastric	stomach
37	chr10:26932000-26932600	Enhancers	K562	blood
38	chr10:26932000-26932800	Enhancers	Fetal Thymus	thymus
39	chr10:26932400-26934400	Weak transcription	Gastric	stomach
40	chr10:26932800-26934400	Weak transcription	Fetal Thymus	thymus
41	chr10:26934400-26935400	Enhancers	Fetal Thymus	thymus
42	chr10:26934400-26935400	Enhancers	Gastric	stomach
43	chr10:26934800-26935400	Genic enhancers	Thymus	Thymus
44	chr10:26934800-26935400	Enhancers	Spleen	Spleen
45	chr10:26934800-26938000	Enhancers	Primary monocytes fromperipheralblood	blood
46	chr10:26935000-26937400	Enhancers	Monocytes-CD14+_RO01746	blood
47	chr10:26935400-26936200	Weak transcription	Fetal Thymus	thymus
48	chr10:26935400-26936400	Weak transcription	Thymus	Thymus
49	chr10:26935400-26936600	Weak transcription	Spleen	Spleen
50	chr10:26935600-26936800	Enhancers	Primary T helper naive cells fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links